S100A11 has been reported to stimulate the production of the pro-inflammatory cytokine IL-6 by peripheral blood mononuclear cells (PBMC) and overexpression of S100A11 was associated with inflammation-related health problems such as osteoarthritis or rheumatoid arthritis [47]. This evidence concerns the gene IL6 and rheumatoid arthritis.